Jump to:

Guidelines and Clinical Updates

RSS

October 2014

Nitrofurantoin: new advice on use in renal impairment

Nitrofurantoin can now be used in patients with moderate renal impairment.

Change to Yellow Card reporting in children

The MHRA no longer requires all suspected adverse drug reactions (ADRs) in...

September 2014

NICE reviews contraception guideline

NICE has updated its clinical guideline on the use of long-acting reversible...

Rienso: hypersensitivity warnings strengthened

Takeda has issued a letter to healthcare professionals about the risk of...

Schools given permission to keep emergency salbutamol inhalers

From October 1st, primary and secondary schools in England may obtain salbutamol...

Flu vaccines updated for 2014/15 season

The influenza vaccine listings in MIMS have been updated for the 2014/15...

MIMS travel tables updated with new rabies and hepatitis B recommendations

The National Travel Health Network and Centre (NaTHNaC) has revised the list...

New MIMS iron supplements table

MIMS now includes a quick-reference table of oral iron supplements and the...

HPV vaccination schedule changes from three to two doses

The MIMS summary of routine childhood immunisations has been updated to reflect...

August 2014

Further oral MS treatment approved by NICE

NICE has accepted dimethyl fumarate (Tecfidera) for NHS use in certain patients...

NICE advises increased statin use

In its updated guideline on lipid modification for the prevention of cardiovascular...

NICE overhauls CKD guideline

NICE has updated its clinical guideline on the diagnosis and treatment of...

Benefits of emergency contraceptives outweigh risks, confirms EMA

A European review has concluded that emergency contraceptives remain suitable for all...

Blood drug levels to be set in new driving offence

A new offence of driving with certain controlled drugs above specified levels...

MIMs Drug Search

Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.

Find drugs by:

Back to top